pantoprazole has been researched along with Barrett Epithelium in 8 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Endoscopic ablation of Barrett's esophagus has been described in which various thermocoagulation modalities are used in combination with a high dose of a proton pump inhibitor." | 2.71 | Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus. ( Cortina, G; Dulai, GS; Fontana, L; Ippoliti, A; Jensen, DM, 2005) |
| "Both acid and bile reflux is significantly suppressed by proton pump inhibitor therapy with exceptions among individual esophagitis patients." | 1.31 | Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy. ( Menges, M; Müller, M; Zeitz, M, 2001) |
| "Gastroesophageal reflux disease has a multifactorial etiology." | 1.31 | Efficacy of medical therapy and antireflux surgery to prevent Barrett's metaplasia in patients with gastroesophageal reflux disease. ( Gadenstaetter, M; Klaus, A; Klingler, PJ; Obrist, P; Profanter, C; Weiss, H; Wetscher, GJ; Wykypiel, H, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babic, Z | 1 |
| Bogdanovic, Z | 1 |
| Dorosulic, Z | 1 |
| Petrovic, Z | 1 |
| Kujundzic, M | 1 |
| Banic, M | 1 |
| Marusic, M | 1 |
| Heinzl, R | 1 |
| Bilić, B | 1 |
| Andabak, M | 1 |
| Lazebnik, LB | 1 |
| Vasil'ev, IuV | 1 |
| Pellicano, R | 1 |
| de Bortoli, N | 1 |
| Martinucci, I | 1 |
| Piaggi, P | 1 |
| Maltinti, S | 1 |
| Bianchi, G | 1 |
| Ciancia, E | 1 |
| Gambaccini, D | 1 |
| Lenzi, F | 1 |
| Costa, F | 1 |
| Leonardi, G | 1 |
| Ricchiuti, A | 1 |
| Mumolo, MG | 1 |
| Bellini, M | 1 |
| Blandizzi, C | 1 |
| Marchi, S | 1 |
| Dulai, GS | 1 |
| Jensen, DM | 1 |
| Cortina, G | 1 |
| Fontana, L | 1 |
| Ippoliti, A | 1 |
| Menges, M | 1 |
| Müller, M | 1 |
| Zeitz, M | 1 |
| Wetscher, GJ | 1 |
| Gadenstaetter, M | 1 |
| Klingler, PJ | 1 |
| Weiss, H | 1 |
| Obrist, P | 1 |
| Wykypiel, H | 1 |
| Klaus, A | 1 |
| Profanter, C | 1 |
| Tröger, U | 1 |
| Stötzel, B | 1 |
| Martens-Lobenhoffer, J | 1 |
| Gollnick, H | 1 |
| Meyer, FP | 1 |
1 review available for pantoprazole and Barrett Epithelium
| Article | Year |
|---|---|
[Proton pump inhibitors, a family of drugs in continuous expansion].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Barrett E | 2000 |
3 trials available for pantoprazole and Barrett Epithelium
| Article | Year |
|---|---|
One year treatment of Barrett's oesophagus with proton pump inhibitors (a multi-center study).
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Barrett Esophagus; Epithelial Cells; Esophagoscopy; Esophag | 2015 |
Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett's oesophagus for 1 year.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Apoptosi | 2011 |
Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Argon; Barrett Esophagus; Benzimidazoles; Combined Modality | 2005 |
4 other studies available for pantoprazole and Barrett Epithelium
| Article | Year |
|---|---|
[Efficacy of pantoprazole in the therapy of esophageal reflux disease].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Barrett Esophagus; Drug Adm | 2008 |
Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Barrett Esophagus; Benzimidazoles; Bile Reflux; Case-Contro | 2001 |
Efficacy of medical therapy and antireflux surgery to prevent Barrett's metaplasia in patients with gastroesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimid | 2001 |
Drug points: Severe myalgia from an interaction between treatments with pantoprazole and methotrexate.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Barrett Esophagus; Benzimidazoles; Dermatologic Agents; Dru | 2002 |